title: Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives.
abstract: Mesenchymal stem/stromal cells (MSCs) are progenitors which share plastic-adherence capacity and cell surface markers but have different properties according to their cell and tissue sources and to culture conditions applied. Many recent publications suggest that MSCs can differentiate into hepatic-like cells, which can be a consequence of either a positive selection of rare in vivo pluripotent cells or of the original plasticity of some cells contributing to MSC cultures. A possible role of MSCs in hereditary transmission of obesity and/or diabetes as well as properties of MSCs regarding immunomodulation, cell fusion and exosome release capacities are discussed according to recent literature. Limitations in methods used to track MSCs in vivo especially in the context of liver cirrhosis are addressed as well as strategies explored to enhance their migratory, survival and proliferation properties, which are known to be relevant for their future clinical use. Current knowledge regarding mechanisms involved in liver cirrhosis amelioration mediated by naïve and genetically modified MSCs as well as the effects of applying preconditioning and combined strategies to improve their therapeutic effects are evaluated. Finally, first reports of GMP guidelines and biosafety issues in MSCs applications are discussed.
authors.affiliation: Gene Therapy Laboratory, Liver Unit, School of Medicine, Austral University, Av. Presidente Perón, B1629ODT, Derqui-Pilar, Buenos Aires, Argentina.
authors.forename: Esteban J
authors.initials: EJ
authors.lastname: Fiore
authors.forename: Guillermo
authors.initials: G
authors.lastname: Mazzolini
authors.forename: Jorge B
authors.initials: JB
authors.lastname: Aquino
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D049109:Cell Proliferation / Q000502:physiology; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology / Q000628:therapy*; D008115:Liver Regeneration / Q000502:physiology; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D008954:Models, Biological; D044968:Regenerative Medicine / Q000379:methods / Q000639:trends
references.citation: J Transl Med. 2013 Mar 26;11:78
references.pmid: 23531302
references.citation: Cell Biol Int. 2012;36(12 ):1267-74
references.pmid: 23035905
references.citation: J Clin Invest. 2005 Feb;115(2):209-18
references.pmid: 15690074
references.citation: Cytotherapy. 2014 Mar;16(3):309-18
references.pmid: 24239106
references.citation: Int J Hepatol. 2012;2012:212530
references.pmid: 23056951
references.citation: J Cell Biol. 2013 Sep 16;202(6):951-66
references.pmid: 24019537
references.citation: Liver Int. 2014 Mar;34(3):330-42
references.pmid: 24112437
references.citation: PLoS One. 2011 Feb 04;6(2):e16789
references.pmid: 21326862
references.citation: Stem Cells. 2013 Aug;31(8):1584-96
references.pmid: 23592412
references.citation: Cell Stem Cell. 2013 Oct 3;13(4):392-402
references.pmid: 24094322